Do you see possible applications for OncoQuick other than the enrichment of disseminated tumor cells?
If we will be able to vary the density of the separation medium the number of possible applications will dramatically increase. This could also help to optimize the recovery rate and enrichment factor with certain tumor entities. Another example: One group used OncoQuick to perform the enrichment of embryonic cells from maternal blood.
Related Questions
- How is it possible to avoid the loss of RNA derived from tumor cells that have been enriched by means of OncoQuick®?
- Do you see possible applications for OncoQuick other than the enrichment of disseminated tumor cells?
- Is it possible to use Leucosep® to perform the enrichment of tumor cells from peripheral blood?
